Syndax Pharmaceuticals SNDX Current Portion Of Capital Lease
Current Portion Of Capital Lease at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept sndx:CurrentPortionOfCapitalLease.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's current portion of capital lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's current portion of capital lease?
- Syndax Pharmaceuticals (SNDX) reported current portion of capital lease of $1K in Q1 2026.
- How has Syndax Pharmaceuticals's current portion of capital lease changed year-over-year?
- Syndax Pharmaceuticals's current portion of capital lease decreased by 85.7% year-over-year, from $7K to $1K.
- What is the long-term trend for Syndax Pharmaceuticals's current portion of capital lease?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's current portion of capital lease has grown at a 18.9% compound annual growth rate (CAGR), from $1K to $2K.
- What does current portion of capital lease mean?
- This represents the portion of long-term lease obligations that must be paid within the upcoming fiscal year. It reflects the company's fixed contractual commitments for leased assets such as equipment or facilities. Managing this liability is vital for maintaining operational continuity and assessing the company's short-term cash flow requirements.